Jump to content

Moramide intermediate

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Frietjes (talk | contribs) at 17:32, 12 October 2015. The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Moramide intermediate
Clinical data
Other namesmoramide intermediate
Routes of
administration
N/A
ATC code
  • none
Legal status
Legal status
Identifiers
  • 3-Methyl-4-morpholin-4-yl-2,2-diphenylbutanoic acid
CAS Number
PubChem CID
ChemSpider
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC21H25NO3
Molar mass339.4281 g/mol g·mol−1
3D model (JSmol)
  • O=C(O)C(c1ccccc1)(c2ccccc2)C(C)CN3CCOCC3
  • InChI=1S/C21H25NO3/c1-17(16-22-12-14-25-15-13-22)21(20(23)24,18-8-4-2-5-9-18)19-10-6-3-7-11-19/h2-11,17H,12-16H2,1H3,(H,23,24)
  • Key:AWLNVHVUYACOMZ-UHFFFAOYSA-N

Moramide intermediate (3-methyl-4-morpholin-4-yl-2,2-diphenylbutanoic acid, on INCB Yellow List as 2-methyl-3-morpholino-1,1-diphenylpropane carboxylic acid) is a moramide precursor scheduled by UN Single Convention on Narcotic Drugs.

In the United States, moramide intermediate is designated as a Schedule II controlled substance.[1]

See also

References